Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution

Mini Kamboj, Nina Cohen, Kathleen Gilhuley, N. Esther Babady, Susan K. Seo, Kent A. Sepkowitz

Infection Control and Hospital Epidemiology · 2011 · 81 citations · 5 references

Concepts

Abstract

Recent surveillance from US hospitals shows that more than 99.5% of vancomycin-resistant enterococci (VRE) isolates remain susceptible to daptomycin. This report describes emergence of daptomycin-resistant VRE at a major cancer center. The percentage of patients with daptomycin-resistant VRE bacteremia increased from 3.4% in 2007 to 15.2% in 2009 ([Formula: see text]). Without susceptibility data, empiric daptomycin therapy for VRE infections should be used with caution.

References

5